Rupture of infectious intracranial aneurysms (IIAs) is associated with a high likelihood of mortality. Endovascular treatment of IIAs via parent artery sacrifice offers good efficacy and outcomes; however, depending on the lesion’s location, neurologic deficit may result.
Case description
We describe a pediatric patient with ruptured IIAs off the left middle cerebral artery (MCA) treated with coil embolization and endovascular flow diversion using the Pipeline Flex Embolization Device (PED) with Shield technology. We chose to place a flow diverter because 1) there was a second, more distal IIA not amenable to direct coil embolization, 2) there was significant potential for aneurysm regrowth and need for retreatment, and 3) we believed the diseased parent MCA needed to be reconstructed.
Conclusions
In the setting of previous hemicraniectomy, PED-Shield gave us the option to discontinue dual antiplatelet therapy should the patient require further neurosurgical intervention. Our case supports a role for PED-Shield to address ruptured pseudoaneurysms.
ChunJYSmithWHalbachVV, et al.
Current multimodality management of infectious intracranial aneurysms. Neurosurgery2001;
48: 1203–1213; discussion 1213–1214.
2.
GrandhiRZwagermanNTLinaresG, et al.
Onyx embolization of infectious intracranial aneurysms. J Neurointerv Surg2014;
6: 353–356.
3.
FloresBCPatelARBragaBP, et al.
Management of infectious intracranial aneurysms in the pediatric population. Childs Nerv Syst2016;
32: 1205–1217.
4.
EddlemanCSSurdellDDiPatriA, et al.
Infectious intracranial aneurysms in the pediatric population: endovascular treatment with onyx. Childs Nerv Syst2008;
24: 909–915.
5.
ReuschelVGrollMQuäschlingU, et al. Middle cerebral artery (M3) aneurysm: atypical primary morphology and early recurrence after stent-assisted coil occlusion during the long-term left ventricular assist device treatment, accompanied by temporary septicemia; parent vessel occlusion as the final treatment with good clinical outcome. In: HenkesHLylykPGanslandtO (eds) The aneurysm casebook: a guide to treatment selection and technique.
Cham:
Springer International Publishing, 2018. DOI: 10.1007/978-3-319-70267-4_76-1
6.
HanDKTadrosROChungC, et al.
Endovascular treatment of 2 synchronous extracranial carotid artery aneurysms using stent-assisted coil embolization and double bare-metal stenting. Vasc Endovascular Surg2016;
50: 102–106.
7.
AppelboomGKadriKHassanF, et al.
Infectious aneurysm of the cavernous carotid artery in a child treated with a new-generation of flow-diverting stent graft: case report. Neurosurgery2010;
66: E623–624; discussion E624.
8.
DingDRaperDMCarswellAJ, et al.
Endovascular stenting for treatment of mycotic intracranial aneurysms. J Clin Neurosci2014;
21: 1163–1168.
9.
HartmannAHoffmannK-TSanderC, et al. Superior cerebellar artery aneurysm: spontaneous subarachnoid hemorrhage and stent-assisted coil occlusion of a ruptured aneurysm at the superior cerebellar artery origin and of an unruptured small basilar artery bifurcation aneurysm, bacterial endocarditis, early major aneurysm recurrence with oculomotor palsy, and treatment of the “mycotic” aneurysm by flow diverter implantation, with resolution of the aneurysm and good clinical recovery. In: HenkesHLylykPGanslandtO (eds) The aneurysm casebook: a guide to treatment selection and technique.
Cham:
Springer International Publishing, 2018. DOI: 10.1007/978-3-319-70267-4_56-1
KobetsAJScocoANakhlaJ, et al.
Flow-diverting stents for the obliteration of symptomatic, infectious cavernous carotid artery aneurysms. Oper Neurosurg2018;
14: 681–685.
12.
MatsudaYJangDKChungJ, et al.
Preliminary outcomes of single antiplatelet therapy for surface-modified flow diverters in an animal model: analysis of neointimal development and thrombus formation using OCT. J NeuroIntervent Surg2019;
11: 74–79.
13.
Martinez-GaldamezMLaminSMLagiosKG, et al.
Periprocedural outcomes and early safety with the use of the pipeline flex embolization device with shield technology for unruptured intracranial aneurysms: preliminary results from a prospective clinical study. J NeuroIntervent Surg2017;
9: 772–776.
14.
HanelRAAguilar-SalinasPBrasilienseLB, et al.
First US experience with pipeline flex with shield technology using aspirin as antiplatelet monotherapy. BMJ Case Rep2017;
2017: bcr219406.
15.
ManningNWCheungAPhillipsTJ, et al.
Pipeline shield with single antiplatelet therapy in aneurysmal subarachnoid haemorrhage: multicentre experience. J NeuroIntervent Surg2019;
11: 694–698.
16.
AgnolettoGJAguilar-SalinasPSantosR, et al.
PED flex with shield technology: a feasible alternative for fusiform MCA aneurysms. Stroke Vasc Neurol2018;
3: 185–188.
17.
GirdharGAndersenAPangerlE, et al.
Thrombogenicity assessment of pipeline flex, pipeline shield, and FRED flow diverters in an in vitro human blood physiological flow loop model. J Biomed Mater Res A2018;
106: 3195–3202.
18.
Lenz-HabijanTBhogalPPetersM, et al.
Hydrophilic stent coating inhibits platelet adhesion on stent surfaces: initial results in vitro. Cardiovasc Intervent Radiol2018;
41: 1779–1785.
19.
Martinez MorenoRBhogalPLenz-HabijanT, et al.
In vivo canine study of three different coatings applied to p64 flow-diverter stents: initial biocompatibility study. Eur Radiol Exp2019;
3: 3.
20.
BhogalPPerezMAWendlC, et al.
Paediatric aneurysms – review of endovascular treatment strategies. J Clin Neurosci2017;
45: 54–59.
21.
NavarroRBrownBLBeierA, et al.
Flow diversion for complex intracranial aneurysms in young children. J Neurosurg Pediatr2015;
15: 276–281.
22.
VargasSADiazCHerreraDA, et al.
Intracranial aneurysms in children: the role of stenting and flow-diversion. J Neuroimaging2016;
26: 41–45.
23.
IsraelsSJMichelsonAD.Antiplatelet therapy in children. Thromb Res2006;
118: 75–83.
24.
DewanMCRavindraVMGannonS, et al.
Treatment practices and outcomes after blunt cerebrovascular injury in children. Neurosurgery2016;
79: 872–878.
25.
RavindraVMBolloRJDewanMC, et al.
Comparison of anticoagulation and antiplatelet therapy for treatment of blunt cerebrovascular injury in children <10 years of age: a multicenter retrospective cohort study. Childs Nerv Syst2021;
37: 47–54.
